{"database": "openregs", "table": "documents", "rows": [["FDA-1975-N-0336-0003", "FDA", "FDA-1975-N-0336", "FDA/OC to PMB Pharmaceuticals, Inc.(Buchanan Ingersoll & Rooney, PC) - Letter", "Other", "Letter(s)", "2011-08-09T04:00:00Z", 2011, 8, "2011-08-09T04:00:00Z", null, "2011-08-09T19:57:46Z", null, 0, 0, "0900006480edc698"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1975-N-0336-0003"], "units": {}, "query_ms": 0.5938049871474504, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}